Newsletter
Newsletter Support JNS

Bennett holds separate calls with Putin, Zelensky

Bennett first spoke with Zelensky, where they spoke about “Russian aggression,” the Ukrainian leader said on Twitter.

Israeli prime minister Naftali Bennett holds a press conference about the Covid-19, at HaKirya base in Tel Aviv, January 11, 2022. Photo by Noam Revkin Fenton/Flash90
Israeli prime minister Naftali Bennett holds a press conference about the Covid-19, at HaKirya base in Tel Aviv, January 11, 2022. Photo by Noam Revkin Fenton/Flash90

Israeli Prime Minister Naftali Bennett spoke with both Russian President Vladimir Putin and Volodymyr Zelensky separately on Wednesday.

Bennett first spoke with Zelensky, where they spoke about “Russian aggression,” the Ukrainian leader said on Twitter.

According to the Kremlin, Bennett initiated the call with Putin, with the Russian leader telling the Israeli leader taking into account Moscow’s security interests was among the key conditions for settling the conflict.

While Israel has expressed support for Ukrainian and provided humanitarian aid to the country, it has been nuanced in its approach to the conflict, especially with its muted criticism of Russia. Israel is especially concerned with maintaining its freedom of action in Syria against Iranian targets, where Russia has military forces.

Nevertheless, Israel did vote to approve the U.N. General Assembly resolution on Wednesday to reprimand Russia for invading Ukraine.

According to reports, Bennett has offered to mediate peace talks between both countries.

Hamas said it is willing to move forward with second stage of the U.S.-brokered framework, calling on Washington to exert pressure on Jerusalem.
“We can and know how to stand our ground—even against our best friends when necessary,” said Prime Minister Benjamin Netanyahu.
A U.S. official said the blockade of Iranian ports would be lifted if Tehran and Muscat finalize an arrangement.
The Tel Aviv-based drug maker is facing an antitrust lawsuit, together with several other pharmaceutical companies.